Is AKTS a high-quality business?

AlphaMadera's AlphaQuality grade scores Aktis Oncology, Inc. on six pillars — profitability, capital efficiency, balance-sheet strength, growth durability, cash generation, and shareholder yield. The composite letter grade reflects how AKTS compares to a Buffett-style quality bar.

What is Aktis Oncology, Inc.'s AlphaQuality grade?

AlphaQuality assigns a letter grade (A through F) to AKTS based on a six-pillar quantitative model. The live page shows the composite grade plus each pillar's individual score with the underlying metrics.

What makes AKTS a quality stock?

AlphaQuality looks at return on capital, free-cash-flow margins, debt-to-equity, revenue stability, dividend and buyback policy, and operating-margin trend. Stocks scoring well across all six pillars earn higher grades — the methodology favors compounders over cyclicals.

AKTS - Aktis Oncology, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $33.00 DETAILS

AlphaQuality

Quantitative six-pillar business-quality grade

High-Growth Software

Ungradable

AlphaQuality requires 5 years of audited income statements; only 4 available.